Cephalon, Inc. (CEPH) - NASDAQ
CEPH is defunct.
From other sites
Company Description
Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system ("CNS"), pain, oncology and inflammatory disease. In addition to conducting an active... More
Sector: Healthcare
Industry: Biotechnology
Country: United States